Agile Therapeutics Inc Valeur / Action
Quel est le Valeur / Action de Agile Therapeutics Inc?
Le Valeur / Action de Agile Therapeutics Inc est -1.04
Quelle est la définition de Valeur / Action?
La valeur comptable par action est l'actif de la société moins le passif divisé par le nombre d'actions en circulation.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valeur / Action des entreprises dans Health Care secteur sur NASDAQ par rapport à Agile Therapeutics Inc
Que fait Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Entreprises avec valeur / action similaire à Agile Therapeutics Inc
- Akerna Corp a Valeur / Action de -1.07
- Predilife S.A a Valeur / Action de -1.07
- Armata Pharmaceuticals Inc a Valeur / Action de -1.06
- C & C Constructions a Valeur / Action de -1.06
- C & C Constructions a Valeur / Action de -1.06
- Xiana Mining a Valeur / Action de -1.05
- Agile Therapeutics Inc a Valeur / Action de -1.04
- Global Wellness Strategies a Valeur / Action de -1.04
- Rochester Resources a Valeur / Action de -1.03
- Les Hotels de Paris SA a Valeur / Action de -1.03
- Uxin Ltd a Valeur / Action de -1.03
- Opthea Ltd a Valeur / Action de -1.02
- Trinseo PLC a Valeur / Action de -1.02